India’s homegrown gut wellness startup Lifechart has raised $500K in a recent funding round, led by Prajay Advisors LLP. This round also saw contributions from multiple investors, including Agility Ventures, Expert Dojo, and angel investors such as Ahana Gautam, Nitish Mittersain (Founder of Nazara Technologies), and Sarath Sura (Founder of Sunn91 Ventures).
Prajay Advisors LLP invested $250,000 in the round, with the rest coming from various other investors. Cignas from NA Shah Advisors LLP acted as the transaction advisor for Lifechart funding round. Notably, the investments were made using convertible instruments, which were converted into equity during this round.
Funding and Product Development
With this new capital, Lifechart aims to strengthen its AI-driven diagnostic capabilities and launch new proprietary solutions. The startup is planning to build a strong presence in tier-1 cities, addressing India’s rising gut health concerns.
Lifechart’s offerings include plant-based, microbiome-focused products crafted by BAMS (Ayurvedic Medicine) and BHMS (Homeopathic Medicine) doctors. These products aim to treat common gut issues like constipation, fatty liver, piles, gas, and acidity.
Mukul Shah, CEO and Co-founder of Lifechart, expressed excitement about the funding, saying, “We are proud to have gained the trust of marquee investors, especially during a tough time for funding. This new capital will help us improve our AI capabilities, launch diagnostic solutions, and build a strong brand for tier-1 cities.”
Expansion Plans and Future Goals
Lifechart is working on expanding its services to underserved regions across India. So far, the startup claims to have impacted over 250,000 customers, primarily from tier-II, tier-III, and tier-IV cities. To meet the increasing demand, Lifechart plans to hire 50 in-house BAMS and BHMS doctors, further boosting its capacity to offer effective gut wellness solutions.
The startup is also developing India’s first gut wellness clinics and supermarkets and plans to open 150 clinics over the next three years. These clinics will create a comprehensive infrastructure for gut health diagnostics and treatment across both urban and rural areas.
Mukul Shah added, “Our focus goes beyond just selling products. We aim to diagnose and treat gut health issues, a critical unmet need in India.”
Looking for More Funding
Lifechart is currently in discussions to raise an additional $1–$2 million from a venture capital firm based in Delhi NCR. These funds will help the startup grow its full-stack model and expand its new product line and clinic services into tier-1 cities.
The global gut health market is expected to reach $18 billion by 2025–26, and Lifechart is positioning itself to become a key player in this fast-growing market.
